These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7078427)

  • 41. Lipid synthesis and apolipoprotein gene expression in hepatocytes in primary culture from (puromycin-induced) nephrotic rats.
    el Boustani S; Ribeiro A; Janvier B; Loriette C; Bensman R; Druet P; Chambaz J; Mangeney M
    Eur J Clin Invest; 1993 Apr; 23(4):211-8. PubMed ID: 8500513
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of epithelial sodium channel in puromycin aminonucleoside-induced unilateral experimental nephrotic syndrome in normal and analbuminemic Nagase rats.
    Yu Z; Schumacher M; Frey BM; Frey FJ; Vogt B
    Nephron Physiol; 2005; 101(3):p51-62. PubMed ID: 16020936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for an underestimation of the shunt pathway of mevalonate metabolism in slices of livers and kidneys from fasted rats and rats in diabetic ketosis.
    Brady PS; Schumann WC; Ohgaku S; Scofield RF; Landau BR
    J Lipid Res; 1982 Dec; 23(9):1317-20. PubMed ID: 6819335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Actinomycin D blocks the hepatic functional albumin mRNA increase in aminonucleoside-nephrotic rats.
    Pedraza-Chaverri J; Huberman A
    Nephron; 1991; 59(4):648-50. PubMed ID: 1766506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Micropuncture study of fluid transfer in aminonucleoside nephrosis in the rat.
    Lewy JE
    Pediatr Res; 1976 Jan; 10(1):30-4. PubMed ID: 1246462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolism in the hypothermically perfused kidney: utilization of mevalonate in the human and in the dog kidney.
    Kleist H; Jonsson O; Lundstam S; Nauclér J; Pettersson S; Scherstén T
    Eur Surg Res; 1982; 14(3):236-44. PubMed ID: 7117329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal iron handling in the nephrotic syndrome.
    Alfrey AC; Hammond WS
    Kidney Int; 1990 Jun; 37(6):1409-13. PubMed ID: 2362400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of estrogen and testosterone on the metabolism of mevalonate by the shunt pathway.
    Brady PS; Scofield RF; Mann S; Landau BR
    J Lipid Res; 1983 Sep; 24(9):1168-75. PubMed ID: 6415196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma and urinary lipids and lipoproteins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside.
    Gherardi E; Calandra S
    Biochim Biophys Acta; 1982 Feb; 710(2):188-96. PubMed ID: 7066357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Arginine vasopressin gene expression in rats with puromycin-induced nephrotic syndrome.
    Pyo HJ; Summer SN; Niederberger M; Kim JK; Schrier RW
    Am J Kidney Dis; 1995 Jan; 25(1):58-62. PubMed ID: 7810534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plantago asiatica L. Ameliorates Puromycin Aminonucleoside-Induced Nephrotic Syndrome by Suppressing Inflammation and Apoptosis.
    Kho MC; Park JH; Han BH; Tan R; Yoon JJ; Kim HY; Ahn YM; Lee YJ; Kang DG; Lee HS
    Nutrients; 2017 Apr; 9(4):. PubMed ID: 28420111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sex difference in human mevalonate metabolism.
    Feingold KR; Wiley MH; Searle GL; Machida BK; Siperstein MD
    J Clin Invest; 1980 Aug; 66(2):361-6. PubMed ID: 7400320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolism of C14 mevalonate by adult and fetal arteries.
    Tulenko TN; Rabinowitz JL
    Artery; 1983; 11(6):450-9. PubMed ID: 6677248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensinogen and aldosterone.
    Pedraza-Chaverrí J; Cruz C; Chávez MT; López A; Ibarra-Rubio ME; Tapia E; Peña JC
    Rev Invest Clin; 1990; 42(2):120-6. PubMed ID: 2267444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine.
    Stæhr M; Buhl KB; Andersen RF; Svenningsen P; Nielsen F; Hinrichs GR; Bistrup C; Jensen BL
    Am J Physiol Renal Physiol; 2015 Aug; 309(3):F235-41. PubMed ID: 25972510
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome.
    Kerlin BA; Waller AP; Sharma R; Chanley MA; Nieman MT; Smoyer WE
    J Am Soc Nephrol; 2015 Dec; 26(12):3009-19. PubMed ID: 25855774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paradoxical increase in nitric oxide synthase activity in hypercholesterolaemic rats with impaired renal function and decreased activity of nitric oxide.
    Rahman MM; Varghese Z; Moorhead JF
    Nephrol Dial Transplant; 2001 Feb; 16(2):262-8. PubMed ID: 11158398
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beneficial effects of orosomucoid on the glomerular barrier in puromycin aminonucleoside-induced nephrosis.
    Hjalmarsson C; Lidell ME; Haraldsson B
    Nephrol Dial Transplant; 2006 May; 21(5):1223-30. PubMed ID: 16410268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mevalonate metabolism by renal tissue in vitro.
    Raskin P; Siperstein MD
    J Lipid Res; 1974 Jan; 15(1):20-5. PubMed ID: 4811213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.